The primary objective of this career development award application is to provide the candidate, Dr. Fay Kastrinos, a gastroenterologist trained in clinical cancer genetics, with the protected time and mentored experience so that she can become an independent investigator of the genetic epidemiology and prevention of inherited colorectal cancer (CRC) syndromes. Building on her clinical expertise and background in public health, the proposed didactic curriculum will provide her with advanced training in genetic and molecular epidemiology and research methods. Her research projects will focus on Lynch Syndrome, the most common inherited CRC syndrome. Lynch Syndrome is caused by mutations in mismatch repair (MMR) genes and its carriers have a near 80% lifetime risk of CRC and other extracolonic cancers in the absence of medical intervention. While in the last 15 years genetic testing has become available for Lynch Syndrome along with specific preventive measures for patients with gene mutations and their family members, physicians often fail to refer appropriate patients for genetic evaluation and testing. A prediction model analogous to the widely accepted BRCAPRO model for BRCA gene testing in Hereditary Breast Ovarian Cancer Syndrome has not been validated for MMR gene testing in Lynch Syndrome. Also, little is known about the prevalence and penetrance of MMR mutations in nonwhite populations and the utility of prediction models in these patients. Recently, three clinical prediction models have been developed for Lynch Syndrome: MMRpredict, MMRpro, and PREMM1,2,6 (prediction of mismatch repair gene mutations in MLH1, MSH2, and MSH6).
The specific aims of the studies in this research proposal are: (1) to compare the performance of the three models in identifying MMR gene mutation carriers in a multi-centered, international cohort of over 5,000 individuals evaluated for Lynch Syndrome;and (2) to assess the performance of PREMM1,2,6 in identifying MMR mutation carriers in over 7,000 African, Asian, Latin/Caribbean American, other nonwhite, and white individuals tested for MMR mutations at Myriad Genetics Laboratories, Inc., and enrolled in the Colon Cancer Family Registry, to determine whether and how to incorporate adjustment for race and ethnicity in the PREMM1,2,6 model. These efforts will identify the best clinical tool to provide patients with a personalized assessment of CRC risk and help us determine the true burden of Lynch Syndrome with the ability to promote cancer prevention and control.
Relevance Genetic information can transform cancer risk identification, facilitate prevention, and reduce healthcare costs. Effective tools and techniques for assessment of possible genetic cancer risk among diverse patient populations can enable health care providers to target clinical genetic testing appropriately and offer preventive measures for cancer control to carriers of predisposing mutations. Although the proposed research focuses on familial colorectal cancer, its methods may be applicable to the prevention of other cancers as new cancer- related genetic tests become available.
|Kastrinos, Fay; Ojha, Rohit P; Leenen, Celine et al. (2016) Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. J Natl Cancer Inst 108:|
|Kastrinos, Fay; Steyerberg, Ewout W (2015) Family matters in lynch syndrome. J Natl Cancer Inst 107:|
|Inra, Jennifer A; Steyerberg, Ewout W; Grover, Shilpa et al. (2015) Racial variation in frequency and phenotypes of APC and MUTYH mutations in 6,169 individuals undergoing genetic testing. Genet Med 17:815-21|
|Stoffel, Elena M; Kastrinos, Fay (2014) Familial colorectal cancer, beyond Lynch syndrome. Clin Gastroenterol Hepatol 12:1059-68|
|Kastrinos, Fay; Stoffel, Elena M (2014) History, genetics, and strategies for cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol 12:715-27; quiz e41-3|
|Kastrinos, Fay; Steyerberg, Ewout W; BalmaÃ±a, Judith et al. (2013) Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut 62:272-9|
|Kastrinos, Fay; BalmaÃ±a, Judith; Syngal, Sapna (2013) Prediction models in Lynch syndrome. Fam Cancer 12:217-28|
|Raymond, Victoria M; Mukherjee, Bhramar; Wang, Fei et al. (2013) Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol 31:1713-8|
|Mercado, Rowena C; Hampel, Heather; Kastrinos, Fay et al. (2012) Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med 14:670-80|
|Kastrinos, Fay; Syngal, Sapna (2012) Screening patients with colorectal cancer for Lynch syndrome: what are we waiting for? J Clin Oncol 30:1024-7|
Showing the most recent 10 out of 14 publications